Antimicrobial resistance in the environment: considerations for current and future risk assessment of veterinary medicinal products - Scientific guideline
Table of contents
The objective of the draft reflection paper is to review available information on the emissions and the environmental fate of veterinary medicinal products as sources of antimicrobial resistance (AMR) and antimicrobial resistant genes to and within the environment, and their risk to human and animal health. The document considers the suitability of the current risk assessment process for AMR and risk mitigation recommendations, and notes knowledge gaps and research needs.
Keywords: antibiotic, environmental fate, human health, animal health, risk assessment, antimicrobial resistance bacteria (ARB), antimicrobial resistance genes (ARGs).
-
List item
Reflection paper on antimicrobial resistance in the environment: considerations for current and future risk assessment of veterinary medicinal products - First version (PDF/919.43 KB)
Adopted
First published: 01/03/2021 -
List item
Overview of comments received on the 'Reflection paper on antimicrobial resistance in the environment: considerations for current and future risk assessment of veterinary medicinal products - First version' (PDF/604.42 KB)
First published: 01/03/2021
EMA/CVMP/ERA/268948/2020 -
List item
Draft reflection paper on antimicrobial resistance in the environment: considerations for current and future risk assessment of veterinary medicinal products - First version (PDF/963.64 KB)
Draft: consultation closed
First published: 21/11/2018
Consultation dates: 21/11/2018 to 31/08/2019
EMA/CVMP/ERA/632109/2014